Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2005
10/06/2005CA2560922A1 Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
10/06/2005CA2560700A1 Tetrahydrocarbazoles and derivatives
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2557745A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
10/06/2005CA2552980A1 Process for cross coupling indoles
10/05/2005EP1582549A1 Flame retardant resin blends based on polymers derived from 2-hydrocarbyl-3,3-Bis(4-Hydroxyaryl)Phthalimidine monomers
10/05/2005EP1581538A1 Tetracyclic 3-substituted indoles having serotonin receptor affinity
10/05/2005EP1581521A1 Fused heterocyclic derivatives as ppar modulators
10/05/2005EP1581493A1 Factor xa inhibitors
10/05/2005EP1581492A1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
10/05/2005EP1581491A1 Indole derivatives as ppar modulators
10/05/2005EP1581487A2 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005EP1581474A1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases
10/05/2005EP1581205A1 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
10/05/2005EP1230217B1 Positive modulators of nicotinic receptor agonists
10/05/2005EP1156039B1 Pyridazin-3-one derivatives and medicines containing the same
10/05/2005EP0621779B1 Indomethacin lysinate for therapeutic use in ophthalmology
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1678581A Indolin phenylsulfonamide derivatives
10/05/2005CN1678580A Iminoalkanpercarboxylic acids
10/05/2005CN1678579A Indole-3-sulphur derivatives
10/05/2005CN1678578A Indoles having anti-diabetic activity
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678306A -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
10/05/2005CN1678305A Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment
10/05/2005CN1677251A Hydrazone-based charge transport materials
10/05/2005CN1677249A Poly(hydrazone)-based charge transport materials
10/05/2005CN1221537C Epimino substituted benzene derivative
10/05/2005CN1221533C 7-amino-1H-indole derivatives
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
10/05/2005CN1221254C New combination of serotonin agonist (5HT2) and antagonist (5HT6) as pharmaceutical formulation
10/04/2005US6951881 (1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
10/04/2005US6951880 Aryl and heteroaryl compounds as antibacterial and antifungal agents
10/04/2005US6951878 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
10/04/2005US6951877 Materials and methods for treating hypercholesterolemia
10/04/2005US6951874 Compounds
10/04/2005US6951852 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
10/04/2005US6951849 Psychological disorders; central nervous system disorders; schizophrenia
10/04/2005US6951848 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
09/2005
09/29/2005WO2005090544A1 Dilution process for imidopercarboxylic acids
09/29/2005WO2005090543A1 Granular compositions
09/29/2005WO2005090512A1 New materials for injecting or transporting holes and organic electroluminescence devices using the same
09/29/2005WO2005090322A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090306A1 Process for the purification of tryptophan
09/29/2005WO2005090305A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
09/29/2005WO2005090304A1 Organic compounds
09/29/2005WO2005090303A1 4- (5- (aminomethyl) -indole-1-ylmethyl) -benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity
09/29/2005WO2005090302A2 Palladium catalyzed indolization of 2-bromo or chloroanilines
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090296A2 N-substituted benzene sulfonamides
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090283A1 Methods of amination
09/29/2005WO2005090282A1 Androgen receptor modulator compounds and methods
09/29/2005WO2005089813A2 Receptor-avid exogenous optical contrast and therapeutic agents
09/29/2005WO2005089747A1 Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
09/29/2005WO2005035495B1 Fibrinogen receptor antagonists and their use
09/29/2005US20050215804 Synthesizing method for compound, and catalyst for synthesis reaction
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215616 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol; treating vaginal and skin atrophy
09/29/2005US20050215614 Substituted indoles and their use as hcv inhibitors
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005US20050215577 Tetrahydrocarbazoles and derivatives
09/29/2005US20050215537 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
09/29/2005US20050214807 Environmental sensitive fluorogenic compounds and their application for singlet oxygen and protein detection
09/29/2005US20050214565 having anthracene skeleton structure; blue light emission
09/29/2005US20050211622 stent graft is a tubular graft supported by the stent; purified small intestine submucosa is impregnating in the synthetic biological polymer or coating with the biological polymer polylactic acid; reduce endoleaks
09/29/2005DE102004012070A1 Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel New cycloalkyl-containing 5-Acylindolinone, their preparation and their use as medicaments
09/29/2005DE102004012069A1 Neue aryl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel New aryl-containing 5-Acylindolinone, their preparation and their use as medicaments
09/29/2005DE102004012068A1 Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel New alkyl-containing 5-Acylindolinone, their preparation and their use as medicaments
09/29/2005CA2560199A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
09/29/2005CA2560195A1 Organic compounds
09/29/2005CA2559919A1 Sulphonamide derivatives
09/29/2005CA2559047A1 N-substituted benzene sulfonamides
09/29/2005CA2558051A1 Palladium catalyzed indolization of 2-bromo or chloroanilines
09/29/2005CA2558030A1 4- (5- (aminomethyl) -indole-1-ylmethyl) -benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity
09/29/2005CA2554855A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1578885A2 Organic electroluminescent element
09/28/2005EP1578725A1 Microsomal triglyceride transfer protein inhibitors
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005EP1578413A2 Ace-inhibitors having antioxidant and no-donor activity
09/28/2005EP1397348B1 Factor xa inhibitor
09/28/2005CN1675218A Novel tricyclic spiropiperidines or spiropyrrolidines
09/28/2005CN1675183A Acutumine and acutumine compound synthesis and use
09/28/2005CN1675182A Indolenine compound, near infrared absorber, and toner containing the same
09/28/2005CN1675181A 2, 3-dihydro-isoindol-1-ones with MAO-B inhibiting activity
09/28/2005CN1675180A Indole, indazole, and benzazole derivative
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1673219A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
09/28/2005CN1220681C Indole derivatives as XA factor inhibitors
09/27/2005US6949678 For resist applications; thermostability, storage stability
09/27/2005US6949669 Organic compounds
09/27/2005US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
09/27/2005US6949572 Antilipemic or antilipolytic agents for treatment of obesity and lipid disorders, S)-N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide
09/27/2005US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators
1 ... 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 ... 458